Please excuse this OT post but this msg is time sensitive . I have in my mind to set up a couple of new topics here in the lounge but I haven't done it yet.
If I set up a new topic not a sole would see it before next week's tour of the co's WORLD CLASS laboratories was long over! I've followed v.IPA Since before its IPO and did that .40 placement and similar no for the $9m pp at a buck. Trading now at .57 and 52 week lows.
They've added several - rumoured to be at least 3 , rumours you can take to the bank - of the largest 10 and 20 largest pharmas in the world in the past several months with advanced discussions with another top 10 apparently. These are co that hadn't heard of or certainly didn't give a crap about the co. 15 mo ago.
Now signing these co doesn't guarantee a fixed amount of work but they haven't gone through the 6 to 12 mo vetting, audit and language process to sign contract terms for nothing.
Now the co needs to execute and prove that what it's successfully done for over 25 years does indeed carry over into the "therapeutic antibodies" space. Much more on that and the opportunity later. But first, next Wed Aug 14 , 2 pm there is going to be a fantastic opportunity to speak to the CEO at their lab in Victoria. RSVP.
www.immunoprecise.com/shareholder-lab-vi...e-antibodies-canada/
ca.proactiveinvestors.com/companies/news...-in-2019-900461.html
It's a potential multi bagger, that's very obvious, just got to execute. (By the way I think GRB has Still got that potential and I am for sure NOT suggesting a switch)